Protocol - Female Contraception Use and Preference in Sickle Cell Disease
- Current Contraception Use - Female
- Current Contraception Use - Male
- Sex Assigned at Birth
- Sexual Function and Satisfaction - Female
Description
The Female Contraception Survey includes eight self-administered questions that assess a participant’s sexual behavior and use of contraception in the past month and in their lifetime.
Specific Instructions
The Sickle Cell Disease Genitourinary Working Group notes some questions in this assessment are sensitive. Investigators should provide a private space for completing assessments and to be prepared to offer appropriate support.
The Sickle Cell Disease Genitourinary Working Group notes that this protocol has been used in females with sickle cell disease.
Availability
Protocol
Female Contraception Survey
1. Have you ever been sexually active?
[ ] Yes
[ ] No.
If yes, ask question 2.
2. What is the biological sex of your most recent sex partner? _________
3. At any time in your life, have you had sex with a male partner?
[ ] Yes
[ ] No.
If yes, answer questions 4-8.
4. How old were you the first time you had sex with a male partner? ____
5. Do you currently have sex with a male partner on a regular basis?
[ ] Yes
[ ] No.
6. Have you ever used birth control, to prevent pregnancy or for another reason?
[ ] Yes
[ ] No.
If yes:
7. Which types of birth control, if any, have you EVER used? Check all that apply.
[ ] Condom
[ ] Pill
[ ] Patch (Ortho Evra™)
[ ] Shot (Depo-Provera™)
[ ] Ring (Nuva Ring™)
[ ] Arm implant (Nexplanon™, formerly Implanon™)
[ ] Copper intrauterine device/IUD (Paragard™)
[ ] Hormonal intrauterine device/IUD (Mirena™, Skyla™, Liletta™)
[ ] Withdrawal (pulling out)
[ ] Rhythm
[ ] Morning after pill (Plan B™, Ella™)
[ ] Other: ______
[ ] I have never used a birth control method.
8. Which types of birth control, if any, have you used in THE PAST MONTH? Check all that apply.
[ ] Condom
[ ] Pill
[ ] Patch (Ortho Evra™)
[ ] Shot (Depo-Provera™)
[ ] Ring (Nuva Ring™)
[ ] Arm implant (Nexplanon™, formerly Implanon™)
[ ] Copper intrauterine device/IUD (Paragard™)
[ ] Hormonal intrauterine device/IUD (Mirena™, Skyla™, Liletta™)
[ ] Withdrawal (pulling out)
[ ] Rhythm
[ ] Morning after pill (Plan B™, Ella™)
[ ] Other: ______
[ ] I have not used a birth control method in the past month.
Personnel and Training Required
None
Equipment Needs
None
Requirements
| Requirement Category | Required |
|---|---|
| Major equipment | No |
| Specialized training | No |
| Specialized requirements for biospecimen collection | No |
| Average time of greater than 15 minutes in an unaffected individual | No |
Mode of Administration
Self-administered questionnaire
Lifestage
Adult
Participants
Adult females over 18 years of age
Selection Rationale
The Female Contraception Survey from Roe et al. (2022) is a brief, self-administered questionnaire that was developed for use among females with sickle cell disease.
Language
English
Standards
| Standard | Name | ID | Source |
|---|
Derived Variables
None
Process and Review
Not applicable
Protocol Name from Source
Female Contraception Survey
Source
Roe, A. H., Lang, B., McAllister, A., Gaitors, M. C., Smith-Whitley, K., Schreiber, C. A., & Sayani, F. (2022). Contraceptive use and preferences among females with sickle cell disease. Contraception, 105, 42–45. https://doi.org/10.1016/j.contraception.2021.08.009
General References
Carvalho, N. S., Braga, J. P., Barbieri, M., Torloni, M. R., Figueiredo, M. S., & Guazzelli, C. A. F. (2017). Contraceptive practices in women with sickle-cell disease. Journal of Obstetrics and Gynaecology, 37(1), 74–77. https://doi.org/10.1080/01443615.2016.1225023
Day, M. E., Stimpson, S. J., Rodeghier, M., Ghafuri, D., Callaghan, M., Zaidi, A. U., … Sharma, D. (2019). Contraceptive methods and the impact of menstruation on daily functioning in women with sickle cell disease. Southern Medical Journal, 112(3), 174–179. https://doi.org/10.14423/SMJ.0000000000000949
Knight-Madden, J., & Barton-Gooden, A. (2009). Contraceptive usage among Jamaican women with sickle cell disease. Contraception, 80(5), 474–478. https://doi.org/10.1016/j.contraception.2009.05.121
O’Brien, S. H., Klima, J., Reed, S., Chisolm, D., Schwarz, E. B., & Kelleher, K. J. (2011). Hormonal contraception use and pregnancy in adolescents with sickle cell disease: Analysis of Michigan Medicaid claims. Contraception, 83(2), 134–137. https://doi.org/10.1016/j.contraception.2010.06.017
Protocol ID
880601
Variables
Export Variables| Variable Name | Variable ID | Variable Description | dbGaP Mapping | |
|---|---|---|---|---|
| PX880601_Female_Contraception_Use_Biological_Sex_Partner | ||||
| PX880601020000 | What is the biological sex of your most more | N/A | ||
| PX880601_Female_Contraception_Use_Birth_Control_Ever_Prevent_Pregnancy | ||||
| PX880601060000 | Have you ever used birth control, to prevent more | N/A | ||
| PX880601_Female_Contraception_Use_Birth_Control_Type_Ever_Used | ||||
| PX880601070100 | Which types of birth control, if any, have more | N/A | ||
| PX880601_Female_Contraception_Use_Birth_Control_Type_Ever_Used_Other | ||||
| PX880601070200 | Which types of birth control, if any, have more | N/A | ||
| PX880601_Female_Contraception_Use_Birth_Control_Type_Past_Month_Used | ||||
| PX880601080100 | Which types of birth control, if any, have more | N/A | ||
| PX880601_Female_Contraception_Use_Birth_Control_Type_Past_Month_Used_Other | ||||
| PX880601080200 | Which types of birth control, if any, have more | N/A | ||
| PX880601_Female_Contraception_Use_Sexually_Active | ||||
| PX880601010000 | Have you ever been sexually active? | N/A | ||
| PX880601_Female_Contraception_Use_Sex_Male_Partner_Age_First_Time | ||||
| PX880601040000 | How old were you the first time you had sex more | N/A | ||
| PX880601_Female_Contraception_Use_Sex_Male_Partner_Any_Time | ||||
| PX880601030000 | At any time in your life, have you had sex more | N/A | ||
| PX880601_Female_Contraception_Use_Sex_Male_Partner_Current | ||||
| PX880601050000 | Do you currently have sex with a male more | N/A | ||
Measure Name
Female Contraception Use
Release Date
August 15, 2023
Definition
This measure can be used to assess contraceptive use among females with sickle cell disease.
Purpose
Females with SCD have a higher baseline risk for blood clots and stroke than the general population and the risk can increase depending on the hormonal composition of the birth control used (progesterone vs. estrogen vs. combination).
Keywords
sickle cell disease, female contraception, sexual function, physical wellness, contraception, hormone
Measure Protocols
| Protocol ID | Protocol Name |
|---|---|
| 880601 | Female Contraception Use and Preference in Sickle Cell Disease |
Publications
There are no publications listed for this protocol.